ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Arches Natural Products, Inc. Lauds Tinnitus Research Linking Biomarkers to Symptom Severity

An online tinnitus supplement retailer highlights the potential for developing tinnitus treatment possibilities, brought about by a study identifying biomarkers indicative of tinnitus symptom severity.

(PRUnderground) May 13th, 2025

For over 25 years, Arches Natural Products, Inc. has been a leading provider of natural supplements for tinnitus sufferers. Their proprietary formulation includes a high potency form of Gingko biloba known as GinkgoMax 26/7®, which is found in their flagship product, Arches Tinnitus Formula®. While it has been instrumental in helping many individuals in their fight to overcome their tinnitus, there is still no cure for the condition.

However, researchers at Mass General Brigham have identified facial biomarkers that will aid in evaluating possible treatments by objectively measuring a person’s response to their symptoms.

Although over 25 million in the United States experience tinnitus, quantifying the severity of the condition has long been elusive. Because only the individual with tinnitus can hear the characteristic ringing, hissing, or buzzing in their ears, researchers have relied on patient reporting and surveys to determine how distressing symptoms are and whether or not they improve with treatment. Finding a reliable method to measure a patient’s reaction to their symptoms will allow researchers to evaluate the effectiveness of new and long-standing treatments, such as hearing aids and sound therapy, as well as herbal treatments like Gingko biloba for tinnitus, which has proven effective for many.

“Many of the treatments we embrace for medical conditions arise from studies that gather evidence that demonstrates they work,” remarked Brent Curtis, CEO of Arches Natural Products. “This type of research and empirical evidence is simply not available for tinnitus treatments because of the nature of the condition. Until now, we have not been able to measure improvement. By identifying biomarkers that change with symptom severity, the team at Mass General has given the tinnitus community that missing piece to allow research to move forward.”

The Mass General Brigham study analyzed the pupil dilation and facial muscle movements of individuals with tinnitus during exposure to pleasant, neutral, and unpleasant sounds. They analyzed this data, assisted by AI technology, and discovered detectable patterns. In patients with severe tinnitus, the pupils became dilated with exposure to all types of sound, indicating a state of distress. Patients with less severe tinnitus showed milder responses. Only upon exposure to unpleasant sounds did they experience pupil dilation and detectable facial reactions.

“While we still don’t have all the answers, this study puts us one step closer to determining which tinnitus treatments work,” stated Curtis. “At Arches Natural Products, we believe in providing science-based treatments and solutions. It is the basis for our line of supplements that help tinnitus.”

To learn more about Archest Natural Products’ supplements for tinnitus or to order supplements online, call 1-800-486-1237 or visit www.TinnitusFormula.com.

About Arches Natural Products, Inc.

Arches Natural Products, Inc. is the leader in alternative herbal and vitamin treatments for tinnitus. Their products have provided relief for thousands of people and are recommended by the top Ear, Nose, and Throat (ENT) doctors.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Arches Natural Products, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

The post Arches Natural Products, Inc. Lauds Tinnitus Research Linking Biomarkers to Symptom Severity first appeared on

Press Contact

Name: Arches Natural Products, Inc.
Phone: 1-855-736-6285
Email: Contact Us

Original Press Release.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.